Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the... see more

Recent & Breaking News (NDAQ:IMNN)

Celsion Announces Completion of OVATION Study and Provides Update on its Immunotherapy Trial in Advanced Stage III and IV Ovarian Cancer

GlobeNewswire July 5, 2017

Technical Research on Biotech Equities -- Celsion, Sarepta Therapeutics, BioMarin Pharma, and ContraVir Pharma

PR Newswire June 23, 2017

Celsion Corporation Announces Cancellation of Registered Direct Offering

GlobeNewswire June 22, 2017

10 Biggest Mid-Day Losers For Monday

Benzinga.com  June 19, 2017

Mid-Day Market Update: Dow Gains 100 Points; Performant Financial Shares Tumble

Benzinga.com  June 19, 2017

Mid-Morning Market Update: Markets Open Higher; EQT To Buy Rice Energy For $6.7B

Benzinga.com  June 19, 2017

Celsion Corporation Announces $5.4 Million Registered Direct Offering

GlobeNewswire June 19, 2017

Stocks To Watch For June 19, 2017

Benzinga.com  June 19, 2017

Mid-Afternoon Market Update: Kroger Falls Following Amazon–Whole Foods Deal; Hornbeck Offshore Shares Spike Higher

Benzinga.com  June 16, 2017

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  June 16, 2017

Mid-Morning Market Update: Markets Open Lower; Amazon To Buy Whole Foods For $13.7 Billion

Benzinga.com  June 16, 2017

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  June 16, 2017

A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Housing Starts, Consumer Sentiment Data

Benzinga.com  June 16, 2017

Celsion Corporation Regains Compliance with NASDAQ Listing Requirements

GlobeNewswire June 14, 2017

11 Biggest Mid-Day Losers For Tuesday

Benzinga.com  June 6, 2017

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  June 6, 2017

Celsion Announces Presentation of OVATION Study Findings at the ASCO 2017 Annual Meeting

GlobeNewswire June 5, 2017

Celsion Corporation Announces Stock Consolidation

GlobeNewswire May 26, 2017

Investor Network: Celsion Corporation to Host Earnings Call

ACCESS Newswire May 12, 2017

Celsion Corporation Reports First Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire May 12, 2017